Cybin

Cybin Set to Revolutionize Psychedelic Therapy with CYB003's Promising Results

Zip2420

Invested

Community Contributor

Published

14 Mar 25

Views

396

n/a

Zip2420's Fair Value

n/a

-29.9%

14.9%

-29.9%

14.9%

You can edit this narrative until May 14 2:38 AM. Then, changes will post as Updates.

Author's Valuation

CA$0n/a

Zip2420's Fair Value

Narrative

Updates0

Zip2420'sFair Value

CA$0

n/a

Future estimation in

Est. Revenue

Current revenue growth rate

74.94%

Pharma revenue growth rate

0.68%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.12%

Calculation

US$0

Earnings '30

21.57x

PE Ratio '30

US$0

Market Cap '30

US$0

Market Cap '30

27.05m

No. shares '30

US$0

Share Price '30

US$0 Share Price '30

Discounted to 2025 @ 5.82% p.a.

US$0

Fair Value '25

US$0 Fair Value '25

Converted to CAD @ 1.0000 USD/CAD Exchange Rate

CA$0

Fair Value '25